Trastuzumab-NH-PEG4-Azide is an anti-Her2 human monoclonal antibody (Trastuzumab) conjugated with NH2-PEG4-Azide on antibody Fc portion site-specific on Q295 by microbial transglutaminase (mTG). The DAR of trastuzumab-NH-PEG4-Azide is n >1.8. >98% of antibody is conjugated. This product is used for research only. It can be used as conjugation with any DBCO chemical compounds in click chemistry.
Product Details |
Species Reactivity | Human |
---|
Host/Isotype | Cell culture/ IgG1 |
---|
Class | Monoclonal |
---|
Type | Antibody-Linker conjugate |
---|
Immunogen | Human Her2 |
---|
DAR (Drug to Antibody Ratio) | >1.8, >98% Ab is conjugated |
---|
Clone | Trastuzumab biosimilar |
---|
Conjugate | Trastuzumab conjugated with NH2-PEG4-Azide |
---|
Purity | >98% |
---|
Molecular Weight | ~150kDa |
---|
Protein Concentration | 2 mg/ml |
---|
Formulation | Lyophilized |
---|
Storage Condition | 4°C for short time, -20°C or -80°C for long time. |
---|
Storage Buffer | 50 mM Sodium Phosphate, 2 mM EDTA, 6% Trehalose, pH7.0 |